4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001179110-22-002324
Chief Operating Officer acquired 1,838 shares (grant or award)
- Chief Operating Officer gave up 681 shares (to pay taxes)
- Chief Operating Officer acquired 1,964 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Tessari Eben · Chief Operating Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-07-15 | Grant or award : show line 1 in the form | +868 | $11.49 | $9,973 | 106,810 | D |
| 2022-01-15 | Grant or award : show line 2 in the form | +970 | $9.63 | $9,341 | 107,780 | D |
| 2022-03-16 | Exercise or conversion : show line 3 in the form | +1,964 | 109,744 | D | ||
| 2022-03-16 | Shares withheld for taxes : show line 4 in the form | −681 | $10.13 | $6,899 | 109,063 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-03-16 | Exercise or conversion : show line 5 in the form Restricted Share Unit | −1,964 | 5,892 | D |
Loading xslF345X03/edgar.xml…